TEMPORAL MUSCLE THICKNESS AS A PROGNOSTIC MARKER IN A REAL-LIFE COHORT OF NEWLY DIAGNOSED MGMT PROMOTER METHYLATED GLIOBLASTOMA PATIENTS: A MULTICENTRIC IMAGING ANALYSIS

被引：0

作者：

Lazaridis, Lazaros ^{[1
,2
]}

Moenninghoff, Christoph ^{[3
]}

Bumes, Elisabeth ^{[4
]}

Spille, Dorothee Caecilia ^{[5
]}

Muether, Michael ^{[5
]}

Schulz, Tim ^{[6
]}

Heider, Sina ^{[7
]}

Agkatsev, Sarina ^{[1
,2
]}

Schmidt, Teresa

Blau, Tobias ^{[8
]}

Oster, Christoph

Stummer, Walter ^{[1
,2
,5
]}

Kessler, Almuth Friederike ^{[6
]}

Seidel, Clemens ^{[7
]}

Grauer, Oliver ^{[9
]}

Hau, Peter ^{[4
,10
]}

Sure, Ulrich ^{[11
]}

Keyvani, Kathy

Herrlinger, Ulrich ^{[12
,13
]}

Kleinschnitz, Christoph

Stuschke, Martin ^{[14
]}

Herrmann, Ken ^{[15
]}

Deuschl, Cornelius ^{[16
]}

Scheffler, Bjoern ^{[17
]}

Kebir, Sied ^{[1
,2
]}

Glas, Martin ^{[1
,2
]}

机构：

[1] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany

[2] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany

[3] Johannes Wesling Klinikum Minden, Univ Inst Radiol Neuroradiol & Nucl Med, Minden, Germany

[4] Regensburg Univ Hosp, Wilhelm Sander Neurooncol Unit, Regensburg, Germany

[5] Univ Hosp Munster, Dept Neurosurg, Munster, Germany

[6] Univ Hosp Wurzburg, Dept Neurosurg, Wurzburg, Germany

[7] Univ Hosp Leipzig, Dept Radiotherapy & Radiat Oncol, Leipzig, Germany

[8] Univ Duisburg Essen, Univ Med Essen, Inst Neuropathol, Essen, Germany

[9] Univ Hosp Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany

[10] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany

[11] Univ Duisburg Essen, Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany

[12] Univ Hosp Bonn, Div Clin Neurooncol, Dept Neurol, Bonn, Germany

[13] Univ Hosp Bonn, Ctr Integrated Oncol, Bonn, Germany

[14] Univ Duisburg Essen, Univ Med Essen, Dept Radiotherapy, Essen, Germany

[15] Univ Duisburg Essen, Univ Med Essen, Dept Nucl Med, Essen, Germany

[16] Univ Duisburg Essen, Univ Med Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany

[17] German Canc Res Ctr, Heidelberg, Germany

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NIMG-34

引用

页数：2

共 50 条

[41] QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS
Herrlinger, Ulrich
Schaefer, Niklas
Steinbach, Joachim
Weyerbrock, Astrid
Hau, Peter
Goldbrunner, Roland
Kohnen, Ralf
Urbach, Horst
Stummer, Walter
Glas, Martin
NEURO-ONCOLOGY, 2014, 16
[42] THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE
Herrlinger, U.
Schaefer, N.
Steinbach, J. P.
Weyerbrock, A.
Hau, P.
Goldbrunner, R.
Leutgeb, B.
Urbach, H.
Stummer, W.
Glas, M.
NEURO-ONCOLOGY, 2014, 16
[43] Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Stupp, Roger
Hegi, Monika E.
Gorlia, Thierry
Erridge, Sara C.
Perry, James
Hong, Yong-Kil
Aldape, Kenneth D.
Lhermitte, Benoit
Pietsch, Torsten
Grujicic, Danica
Steinbach, Joachim Peter
Wick, Wolfgang
Tarnawski, Rafal
Nam, Do-Hyun
Hau, Peter
Weyerbrock, Astrid
Taphoorn, Martin J. B.
Shen, Chiung-Chyi
Rao, Nalini
Thurzo, Laszlo
Herrlinger, Ulrich
Gupta, Tejpal
Kortmann, Rolf-Dieter
Adamska, Krystyna
McBain, Catherine
Brandes, Alba A.
Tonn, Joerg Christian
Schnell, Oliver
Wiegel, Thomas
Kim, Chae-Yong
Nabors, Louis Burt
Reardon, David A.
van den Bent, Martin J.
Hicking, Christine
Markivskyy, Andriy
Picard, Martin
Weller, Michael
LANCET ONCOLOGY, 2014, 15 (10): : 1100 - 1108
[44] Additional Risk Factors of Severe Bleeding in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML): Ukrainian Prospective Study in a Real-Life Cohort
Stupakova, Zinaida
Dyagil, Iryna
Martina, Zoya
Sergeieva, Anna
Karnabeda, Oksana
Melnyk, Ulyana
Novosad, Olga
Rushkovsky, Stanislav
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S298 - S298
[45] Evaluation of Participation and Recruitment Bias in a Prospective Real-Life Multicentric Cohort ⟪ Real World Data in Lymphoma and Survival in Adults ⟫ (REALYSA study) for Newly Diagnosed Lymphoma Patients over One Year in a Hematology Department of Teaching Hospital
Lan, Caroline L. E.
Belot, Aurelien
Golfier, Camille
Audin, Berenice
Sesques, Pierre
Bernier, Adeline
Safar, Violaine
Marquet, Alexandra
Ferrant, Emmanuelle
Lazareth, Anne
Lequeu, Helene
Bouafia, Fadhela
Karlin, Lionel
Ghergus, Dana
Maarek, Alizee
Aussedat, Guillaume
Idlhaj, Maryam
Salles, Gilles
Cherblanc, Fanny
Bachy, Emmanuel
Ghesquieres, Herve
BLOOD, 2022, 140 : 5210 - 5211
[46] Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Herrlinger, Ulrich
Tzaridis, Theophilos
Mack, Frederic
Steinbach, Joachim Peter
Schlegel, Uwe
Sabel, Michael
Hau, Peter
Kortmann, Rolf-Dieter
Krex, Dietmar
Grauer, Oliver
Goldbrunner, Roland
Schnell, Oliver
Baehr, Oliver
Uhl, Martin
Seidel, Clemens
Tabatabai, Ghazaleh
Kowalski, Thomas
Ringel, Florian
Schmidt-Graf, Friederike
Suchorska, Bogdana
Brehmer, Stefanie
Weyerbrock, Astrid
Renovanz, Miriam
Bullinger, Lars
Galldiks, Norbert
Vajkoczy, Peter
Misch, Martin
Vatter, Hartmut
Stuplich, Moritz
Schaefer, Niklas
Kebir, Sied
Weller, Johannes
Schaub, Christina
Stummer, Walter
Tonn, Joerg-Christian
Simon, Matthias
Keil, Vera C.
Nelles, Michael
Urbach, Horst
Coenen, Martin
Wick, Wolfgang
Weller, Michael
Fimmers, Rolf
Schmid, Matthias
Hattingen, Elke
Pietsch, Torsten
Coch, Christoph
Glas, Martin
LANCET, 2019, 393 (10172): : 678 - 688
[47] AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
Todisco, Elisabetta
Papayannidis, Cristina
Fracchiolla, Nicola
Petracci, Elisabetta
Zingaretti, Chiara
Vetro, Calogero
Martelli, Maria Paola
Zappasodi, Patrizia
Di Renzo, Nicola
Gallo, Susanna
Audisio, Ernesta
Griguolo, Davide
Cerchione, Claudio
Selleri, Carmine
Mattei, Daniele
Bernardi, Massimo
Fumagalli, Monica
Rizzuto, Giuliana
Facchini, Luca
Basilico, Claudia Maria
Manfra, Ilenia
Borlenghi, Erika
Cairoli, Roberto
Salutari, Prassede
Gottardi, Michele
Molteni, Alfredo
Martini, Vincenza
Lunghi, Monia
Fianchi, Luana
Cilloni, Daniela
Lanza, Francesco
Abruzzese, Elisabetta
Cascavilla, Nicola
Rivellini, Flavia
Ferrara, Felicetto
Maurillo, Luca
Nanni, Jacopo
Romano, Alessandra
Cardinali, Valeria
Gigli, Federica
Roncoroni, Elisa
Federico, Vincenzo
Marconi, Giovanni
Volpi, Roberta
Sciume, Mariarita
Tarella, Corrado
Rossi, Giuseppe
Martinelli, Giovanni
CANCER, 2023, 129 (07) : 992 - 1004
[48] STANDARD DOSE (SD) VERSUS LOW DOSE (LD) OF IMATINIB IN A "REAL-LIFE" COHORT OF VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA
Capodanno, I.
Latagliata, R.
Breccia, M.
Ferrero, D.
Trawinska, M.
Castagnetti, F.
Annunziata, M.
Stagno, F.
Tiribelli, M.
Binotto, G.
Fava, C.
Crisa, E.
Mansueto, G.
Gozzini, A.
Falzetti, F.
Montefusco, E.
Iurlo, A.
Russo, S.
Cedrone, M.
Rossi, A. Russo
Gugliotta, G.
Pregno, P.
Isidori, A.
Mauro, E.
Romano, A.
Giglio, G.
Celesti, F.
Sora, F.
Storti, S.
D'Addosio, A. M.
Galimberti, S.
Orlandi, E.
Calistri, E.
Bocchia, M.
Cavazzini, F.
Cambrin, G. Rege
Luciano, L.
Abruzzese, E.
Bonifacio, M.
Sgherza, N.
Crugnola, M.
HAEMATOLOGICA, 2017, 102 : 87 - +
[49] EFFECTIVENESS OF DABRAFENIB-TRAMETINIB AND LAROTRECTINIB IN ADULT RECURRENT GLIOBLASTOMA PATIENTS: A REAL-LIFE COHORT ANALYSIS FROM 3 ITALIAN CENTERS
Padovan, M.
Cella, E.
Bosio, A.
Maccari, M.
Cerretti, G.
Caccese, M.
Corra, M.
Giordano, P.
Bennicelli, E.
Lombardi, G.
NEURO-ONCOLOGY, 2024, 26
[50] Effectiveness of dabrafenib-trametinib and larotrectinib in adult recurrent glioblastoma patients: A real-life cohort analysis from 3 Italian centers
Padovan, M.
Cella, E.
Bosio, A.
Maccari, M.
Cerretti, G.
Caccese, M.
Corra, M.
Giordano, P.
Bennicelli, E.
Lombardi, G.
ANNALS OF ONCOLOGY, 2024, 35 : S414 - S414

← 1 2 3 4 5 →